The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
HIF 抑制线粒体和脂质积累对肿瘤生长的影响
基本信息
- 批准号:10212325
- 负责人:
- 金额:$ 67.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:Automobile DrivingBiogenesisBody fatCarbohydratesCell HypoxiaCell RespirationCellsClear CellDefectEquilibriumExhibitsExposure toFamilyFastingFatty AcidsFatty LiverGenesGenetic TranscriptionGlutamineGlycogenGlycolysisGoalsGrantHistologicHomeostasisHypoxiaIntracellular Accumulation of LipidsKidneyLinkLipidsMalignant NeoplasmsMetabolicMetabolismMitochondriaModalityMolecularMusMutationNuclearOxygen ConsumptionPPAR gammaPhenotypePhysiologyProductionProximal Kidney TubulesReactive Oxygen SpeciesRegulationRenal Cell CarcinomaRepressionRoleSignal TransductionSolid NeoplasmSourceTherapeuticThermogenesisTissuesTranscriptional ActivationTumor ExpansionTumor Suppressor GenesWild Type Mousecancer therapygenomic locusglucose uptakelipid biosynthesislipid metabolismnovelnovel therapeuticsoxidationpublic health relevancerespiratoryresponsetherapeutic targettranscription factortumortumor growthtumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The frequently altered expression of metabolism genes in solid tumors such as clear cell renal cell cancer (ccRCC) has reinforced the importance of dysregulated metabolism in driving tumor expansion. Indeed, constitutive activation of the hypoxia inducible transcription factor (HIF) through mutations in the von Hippel Lindau (VHL) tumor suppressor gene or through exposure to hypoxia, results in enhanced glucose uptake, glycolytic flux, lactate secretion and suppression of mitochondrial activity. Conversely, reactive oxygen species produced by the mitochondria stimulate HIF-dependent transcription, creating an intricate signaling loop that balances mitochondrial oxygen consumption with the cellular response to hypoxia. In addition to stimulating glycolysis while suppressing OXPHOS, hypoxia has also been demonstrated to stimulate de novo lipogenesis through reductive glutamine metabolism, although it has not yet known how this reductive glutamine metabolism contributes to lipid accumulation in solid tumors and the clear cell phenotype in ccRCC. Importantly, HIF-dependent metabolic changes have been exploited therapeutically, indicating that a more comprehensive understanding of HIF regulated metabolism may yield novel anti-cancer therapies. Oxidative metabolism, which broadly encompasses carbohydrate oxidation, glutamine oxidation, and fatty acid ß-oxidation, is controlled by a number of nuclear and mitochondrial transcription factors that together promote the biogenesis and enzymatic function of mitochondria and is often found repressed in many tumors including ccRCC. First identified for their role in promoting adaptive thermogenesis, the peroxisome proliferator activated receptor gamma coactivators PGC-1 and PGC-1ß promote mitochondrial biogenesis and OXPHOS activity in a wide range of tissues by stimulating the transcriptional activation potential of a number of nuclear transcription factors. PGC-1 and PGC-1ß are encoded by discrete genetic loci and exhibit both distinct and redundant transcriptional targets. Indeed, PGC-1 -/- mice exhibit multi-tissue defects in oxidative metabolism, indicating unique functions for PGC-1 that cannot be compensated for by PGC-1ß. Furthermore, PGC-1 deficient mice accumulate significantly more body fat than wild type mice, and develop fasting induced hepatic steatosis, suggesting an important role for PGC-1 in the regulation of lipid metabolism. While the functions of the PGC family have been extensively studied in normal physiology, their function in the context of malignancy has not been rigorously investigated. Our recent studies indicate that PGC-1 is suppressed in ccRCC through a HIF-/Dec1 transcriptional axis. The suppression of PGC-1 in VHL-wild type renal proximal tubule cells is associated with reduced mitochondrial activity and acquisition of the clear cell (lipid and glycogen accumulation) phenotype, a histological hallmark of ccRCC. These findings provide the first evidence linking the clear cell phenotype to multiple aspects of renal tumorigenesis and raise the potential for PGC-1 stimulation as a novel therapeutic modality in the treatment of renal cell carcinoma, and potentially other solid tumors. The goals of this grant are to explore the molecular mechanisms governing lipid homeostasis in cancer, characterize their contribution to tumorigenesis and identify ways that they can be therapeutically targeted in solid tumors and determine how to best exploit them therapeutically.
描述(由申请人提供):实体瘤(例如透明细胞肾细胞癌(ccRCC))中代谢基因的表达频繁改变增强了代谢失调在驱动肿瘤扩张中的重要性。事实上,缺氧诱导转录因子的组成性激活( HIF)通过 von Hippel Lindau (VHL) 肿瘤抑制基因的突变或通过暴露于缺氧,导致葡萄糖摄取、糖酵解通量、乳酸分泌和线粒体抑制增强离线时,线粒体产生的活性氧会刺激 HIF 依赖性转录,从而形成一个复杂的信号环路,平衡线粒体耗氧量与细胞对缺氧的反应。通过还原性谷氨酰胺代谢从头进行脂肪生成,尽管目前尚不清楚这种还原性谷氨酰胺代谢如何促进实体瘤中的脂质积累以及 ccRCC 中的透明细胞表型。重要的是,HIF 依赖性代谢变化。氧化代谢广泛包括碳水化合物氧化、谷氨酰胺氧化和脂肪酸β-氧化,这表明对 HIF 调节代谢的更全面了解可能会产生新的抗癌疗法。线粒体转录因子共同促进线粒体的生物发生和酶功能,并且在包括 ccRCC 在内的许多肿瘤中经常被发现受到抑制,过氧化物酶体首先因其在促进适应性产热中的作用而被识别。增殖细胞激活受体γ共激活剂PGC-1α和PGC-1β通过刺激由其编码的许多核转录因子的转录激活电位来促进多种组织中的线粒体生物发生和OXPHOS活性。事实上,PGC-1α -/- 小鼠在氧化代谢中表现出多组织缺陷,这表明其具有独特的特征。 PGC-1β 的功能无法被 PGC-1ß 补偿。此外,PGC-1α 缺陷小鼠比野生型小鼠积累更多的体脂肪,并出现禁食诱导的肝脂肪变性,这表明 PGC-1β 具有重要作用。虽然 PGC 家族的功能在正常生理学中已得到广泛研究,但我们最近的研究表明,它们在恶性肿瘤中的功能尚未得到严格研究。 PGC-1α 在 ccRCC 中通过 HIF-α/Dec1 转录轴受到抑制 VHL 野生型肾近曲小管细胞中 PGC-1α 的抑制与线粒体活性降低和透明细胞(脂质和糖原)的获得有关。这些发现提供了将透明细胞表型与肾肿瘤发生的多个方面联系起来的第一个证据,并提高了将透明细胞表型与肾肿瘤发生的多个方面联系起来的可能性。 PGC-1 刺激作为治疗肾细胞癌和其他潜在实体瘤的一种新型治疗方式,该资助的目标是探索控制癌症脂质稳态的分子机制,描述其对肿瘤发生的贡献并确定其方法。它们可以作为实体瘤的治疗靶点,并确定如何最好地利用它们进行治疗。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma.
- DOI:10.1186/s40170-022-00290-z
- 发表时间:2022-10-03
- 期刊:
- 影响因子:5.9
- 作者:
- 通讯作者:
Suppressing Mitochondrial Respiration Is Critical for Hypoxia Tolerance in the Fetal Growth Plate.
- DOI:10.1016/j.devcel.2019.04.029
- 发表时间:2019-06
- 期刊:
- 影响因子:11.8
- 作者:Qing Yao;M. Khan;C. Merceron;Edward L LaGory;Zachary Tata;L. Mangiavini;Jiarui Hu;Krishna G. Vemulapalli;N. Chandel;A. Giaccia;E. Schipani
- 通讯作者:Qing Yao;M. Khan;C. Merceron;Edward L LaGory;Zachary Tata;L. Mangiavini;Jiarui Hu;Krishna G. Vemulapalli;N. Chandel;A. Giaccia;E. Schipani
Increased tissue stiffness triggers contractile dysfunction and telomere shortening in dystrophic cardiomyocytes.
- DOI:10.1016/j.stemcr.2021.04.018
- 发表时间:2021-09-14
- 期刊:
- 影响因子:5.9
- 作者:Chang ACY;Pardon G;Chang ACH;Wu H;Ong SG;Eguchi A;Ancel S;Holbrook C;Ramunas J;Ribeiro AJS;LaGory EL;Wang H;Koleckar K;Giaccia A;Mack DL;Childers MK;Denning C;Day JW;Wu JC;Pruitt BL;Blau HM
- 通讯作者:Blau HM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amato J. Giaccia其他文献
Benzamides substitués et leurs utilisations
苯甲酰胺替代品和用途
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
M. Bonnet;Denise A. Chan;Amato J. Giaccia;Michael Patrick Hay;Edwin W. Lai;Olga V. Razorenova;Connie Sun;Ray Tabibiazar;Po - 通讯作者:
Po
Amato J. Giaccia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amato J. Giaccia', 18)}}的其他基金
Project 1: Inhibition of Complement C5aR1 Radioprotects Normal Tissue and Radiosensitizes Tumors
项目 1:抑制补体 C5aR1 辐射保护正常组织并使肿瘤辐射增敏
- 批准号:
10707880 - 财政年份:2022
- 资助金额:
$ 67.29万 - 项目类别:
Project 1: Inhibition of Complement C5aR1 Radioprotects Normal Tissue and Radiosensitizes Tumors
项目 1:抑制补体 C5aR1 辐射保护正常组织并使肿瘤辐射增敏
- 批准号:
10334199 - 财政年份:2022
- 资助金额:
$ 67.29万 - 项目类别:
Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer
针对晚期肾癌 AXL 的新疗法的临床前测试
- 批准号:
8949353 - 财政年份:2016
- 资助金额:
$ 67.29万 - 项目类别:
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
HIF 抑制线粒体和脂质积累对肿瘤生长的影响
- 批准号:
9976465 - 财政年份:2015
- 资助金额:
$ 67.29万 - 项目类别:
HIF-1alpha, a Survival and Differentiation Factor for Cartilage
HIF-1alpha,软骨的存活和分化因子
- 批准号:
8609400 - 财政年份:2013
- 资助金额:
$ 67.29万 - 项目类别:
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
缺氧和 CTGF 对肿瘤和转移性生长的调节
- 批准号:
8492949 - 财政年份:2011
- 资助金额:
$ 67.29万 - 项目类别:
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
缺氧和 CTGF 对肿瘤和转移性生长的调节
- 批准号:
8208641 - 财政年份:2011
- 资助金额:
$ 67.29万 - 项目类别:
相似国自然基金
基于新框架土壤生物促进或抑制外来植物入侵发生条件和机制研究
- 批准号:32371749
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
Baz2b通过抑制线粒体生物发生途径促进脑缺血后神经功能损伤的表观遗传机制研究
- 批准号:82301658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生物钟基因Clk/Cyc通过组蛋白修饰调控异色瓢虫滞育发生的分子机制
- 批准号:32370549
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
生物钟紊乱介导的腺泡铁—铜离子代谢稳态失衡促进胰腺外分泌功能不全发生发展的机制研究
- 批准号:82370656
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于“肾主骨生髓”探讨补肾活血方调控多巴胺受体促进BMSCs线粒体生物发生干预骨质疏松症的机制
- 批准号:82305115
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Assessing the Interrelationship Between Adipose Tissue Thermogenesis and Fibrosis in the Metabolic Health of People Living with HIV
评估艾滋病毒感染者代谢健康中脂肪组织产热与纤维化之间的相互关系
- 批准号:
10626188 - 财政年份:2022
- 资助金额:
$ 67.29万 - 项目类别:
Deciphering age-dependent beige adipocyte failure
解读年龄依赖性米色脂肪细胞衰竭
- 批准号:
10589822 - 财政年份:2022
- 资助金额:
$ 67.29万 - 项目类别:
Composition, sorting, and morphology of the apical plasma membrane in epithelial cells.
上皮细胞顶端质膜的组成、分类和形态。
- 批准号:
10549302 - 财政年份:2021
- 资助金额:
$ 67.29万 - 项目类别:
Composition, sorting, and morphology of the apical plasma membrane in epithelial cells.
上皮细胞顶端质膜的组成、分类和形态。
- 批准号:
10668092 - 财政年份:2021
- 资助金额:
$ 67.29万 - 项目类别:
Composition, sorting, and morphology of the apical plasma membrane in epithelial cells.
上皮细胞顶端质膜的组成、分类和形态。
- 批准号:
10386333 - 财政年份:2021
- 资助金额:
$ 67.29万 - 项目类别: